Projects per year
Personal profile
Chinese Name
王璐瑤
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Luyao WANG is active. Topic labels come from the works of this scholar.
- 1 Similar Scholars
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Osteoblastic sclerostin loop3-LRP4 interaction could be required by sclerostin to inhibit bone formation
ZHANG, G. (PI) & WANG, L. (CoI)
1/01/25 → 31/12/27
Project: Research project
-
Development of Small-molecule Inhibitors Targeting Sclerostin Loop3 for Osteoporosis
ZHANG, G. (PI) & WANG, L. (CoPI)
1/04/23 → 31/03/25
Project: Research project
-
-
DeepAptamer: Advancing high-affinity aptamer discovery with a hybrid deep learning model
Yang, X., Chan, C. H., Yao, S., Chu, H. Y., Lyu, M., Chen, Z., Xiao, H., Ma, Y., Yu, S., Li, F., Liu, J., Wang, L., Zhang, Z., Zhang, B. T., Zhang, L., Lu, A., Wang, Y., Zhang, G. & Yu, Y., 11 Mar 2025, In: Molecular Therapy Nucleic Acids. 36, 1, 15 p., 102436.Research output: Contribution to journal › Journal article › peer-review
Open Access -
Regulating chemoresistance and cancer stemness: the CDH17-YAP pathway in distinct cellular states of lung cancer CTC clusters
Que, Z., Qi, D., Yang, Y., Yao, W., Liu, J., Li, Y., Yu, Y., Wang, L., Li, F., Zhang, G., Wu, E. & Tian, J., 24 Feb 2025, In: Cellular and Molecular Biology Letters. 30, 1, 18 p., 23.Research output: Contribution to journal › Journal article › peer-review
Open Access -
Intracellular sclerostin plays a vital role in tumor progression and metastasis in triple-negative breast cancer
Sun, M., Qiao, S., Luo, H., Yang, X., Yang, L., Zhang, H., Chen, Z., Wang, L., Tao, X., Yu, Y., Ma, Y., Yuan, F., Ma, D., Chen, Q., Lu, A., Zhang, B. T., Zhang, G. & Li, F., 1 Feb 2024, In: Cancer Research. 84, 3, Supplement 1, B044.Research output: Contribution to journal › Conference article › peer-review
-
Sclerostin inhibition in rare bone diseases: Molecular understanding and therapeutic perspectives
Tao, X., Wang, L., Yang, X., Jiang, H., Zhang, N., Zhang, H., Li, D., Li, X., Zhang, Y., Wang, S., Zhong, C., Yu, S., Ren, M., Sun, M., Li, N., Chen, T., Ma, Y., Li, F., Liu, J. & Yu, Y. & 3 others, , Jul 2024, In: Journal of Orthopaedic Translation. 47, p. 39-49 11 p.Research output: Contribution to journal › Journal article › peer-review
Open Access1 Citation (Scopus) -
Targeting osteoblastic 11β-HSD1 to combat high-fat diet-induced bone loss and obesity
Zhong, C., Li, N., Wang, S., Li, D., Yang, Z., Du, L., Huang, G., Li, H., Yeung, W. S., He, S., Ma, S., Wang, Z., Jiang, H., Zhang, H., Li, Z., Wen, X., Xue, S., Tao, X., Li, H. & Xie, D. & 22 others, , 4 Oct 2024, In: Nature Communications. 15, 1, 18 p., 8588.Research output: Contribution to journal › Journal article › peer-review
Open Access
Press/Media
-
From Molecular Target to Aptamer Drug Discovery towards US-FDA Orphan Drug Designation
YU, Y., ZHANG, G., LYU, A. & WANG, L.
19/12/22 → 20/12/22
4 Media contributions
Press/Media